tepmetko tepotinib hydrochloride tablet

1 INDICATIONS AND USAGE TEPMETKO is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition ( MET ) exon 14 skipping alterations. TEPMETKO is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition ( MET ) exon 14 skipping alterations. ( 1 )

emd serono, inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] off label use` `[4] pain` `[5] nausea` `[6] headache` `[7] dyspnoea` `[8] arthralgia` `[9] diarrhoea` `[10] pyrexia`

3 years ago

OVAL PINK M

16 HOW SUPPLIED/STORAGE AND HANDLING TEPMETKO (tepotinib) tablets: 225 mg tepotinib, white-pink, oval, biconvex film-coated tablet with embossment "M" on one side and plain on the other side. NDC number Size 44087-5000-3 Box of 30 tablets: 3 blister cards each containing 10 tablets 44087-5000-6 Box of 60 tablets: 6 blister cards each containing 10 tablets The blister cards consist of a child-resistant blister foil. Store TEPMETKO at 20°C-25°C (68°F-77°F); excursions permitted to 15°C-30°C (59°F-86°F) [see USP-NF Controlled Room Temperature]. Store in original package.

More pills like OVAL M

Related Pills

midol bloat relief pamabrom 50 mg

bayer healthcare llc.

nicorette nicotine polacrilex lozenge

glaxosmithkline consumer healthcare holdings

nicorette lozenge 2 mg

glaxosmithkline consumer healthcare holdings

furosemide 20 mg oral tablet

mylan pharmaceuticals inc.

APAP 325 MG tramadol hydrochloride 37.5 MG Oral Tablet

Mylan Pharmaceuticals Inc.

Alprazolam 0.5 MG Oral Tablet

Mylan Pharmaceuticals Inc.

omeprazole 40 MG Delayed Release Capsule

Mylan Pharmaceuticals Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site